These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 15515031)
41. Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease. Apostolakis EE; Baikoussis NG; Tselikos D; Koniari I; Prokakis C; Fokaeas E; Karanikolas M J Cardiothorac Surg; 2009 Nov; 4():65. PubMed ID: 19912629 [TBL] [Abstract][Full Text] [Related]
42. Valvular health disease with pergolide. Prescrire Int; 2003 Dec; 12(68):225. PubMed ID: 14986695 [No Abstract] [Full Text] [Related]
46. Medical hazards of the internet: gambling in Parkinson's disease. Larner AJ Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457 [No Abstract] [Full Text] [Related]
47. [Impulse control disorder induced by the use of dopamine agonists]. Weber WE; Nijssen PC Ned Tijdschr Geneeskd; 2009 Jan; 153(3):80-1. PubMed ID: 19235343 [No Abstract] [Full Text] [Related]
48. Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both. Ozer F; Tiras R; Cetin S; Ozturk O; Aydemir T; Ozben S; Meral H; Kizkin S; Bader H; Ozben B J Clin Neurosci; 2009 Jan; 16(1):83-7. PubMed ID: 19014887 [TBL] [Abstract][Full Text] [Related]
49. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Comella CL; Morrissey M; Janko K Neurology; 2005 Apr; 64(8):1450-1. PubMed ID: 15851743 [TBL] [Abstract][Full Text] [Related]
54. Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review. Steiger M; Jost W; Grandas F; Van Camp G J Neural Transm (Vienna); 2009 Feb; 116(2):179-91. PubMed ID: 19142570 [TBL] [Abstract][Full Text] [Related]